Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia

Molecular Cancer

Research

Kunrong Cheng¹  Nirish Shah¹  Guofeng Xie¹  Jean-Pierre Raufman²  Sandeep Khurana³  Cinthia B Drachenberg⁴  Jonathon Heath⁴  Jennifer Timmons⁵ 

[1] Department of Medicine, Division of Gastroenterology & Hepatology and Program in Oncology, Marlene and Stewart Greenebaum Cancer Center, VA Maryland Health Care System and University of Maryland School of Medicine, 21201-1595, Baltimore, MD, USA;Department of Medicine, Division of Gastroenterology & Hepatology and Program in Oncology, Marlene and Stewart Greenebaum Cancer Center, VA Maryland Health Care System and University of Maryland School of Medicine, 21201-1595, Baltimore, MD, USA;Division of Gastroenterology & Hepatology, 22 S. Greene St., N3W62, 21201-1595, Baltimore, MD, USA;Department of Medicine, Division of Gastroenterology, Georgia Regents University, 30912, Augusta, GA, USA;Department of Pathology, Division of Anatomic Pathology, University of Maryland School of Medicine, 21201-1595, Baltimore, MD, USA;Department of Surgery, University of Maryland School of Medicine, 21201-1595, Baltimore, MD, USA;

关键词: Muscarinic receptors;    M3R;    M1R;    Chrm1;    Chrm3;    Mouse models;    Colon cancer;    Azoxymethane;    ZNF277;   

DOI  :  10.1186/1476-4598-13-77

 received in 2014-01-07, accepted in 2014-03-27,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundM3 and M1 subtype muscarinic receptors are co-expressed in normal and neoplastic intestinal epithelial cells. In mice, ablating Chrm3, the gene encoding M3R, robustly attenuates intestinal tumor formation. Here we investigated the effects of Chrm1 gene ablation, alone and in combination with Chrm3 ablation.MethodsWe used wild-type, Chrm1-/-, Chrm3-/- and combined Chrm1-/-/Chrm3-/- knockout (dual knockout) mice. Animals were treated with azoxymethane, an intestine-selective carcinogen. After 20 weeks, colon tumors were counted and analyzed histologically and by immunohistochemical staining. Tumor gene expression was analyzed using microarray and results validated by RT-PCR. Key findings were extended by analyzing gene and protein expression in human colon cancers and adjacent normal colon tissue.ResultsAzoxymethane-treated Chrm3-/- mice had fewer and smaller colon tumors than wild-type mice. Reductions in colon tumor number and size were not observed in Chrm1-/- or dual knockout mice. To gain genetic insight into these divergent phenotypes we used an unbiased microarray approach to compare gene expression in tumors from Chrm3-/- to those in wild-type mice. We detected altered expression of 430 genes, validated by quantitative RT-PCR for the top 14 up- and 14 down-regulated genes. Comparing expression of this 28-gene subset in tumors from wild-type, Chrm3-/-, Chrm1-/- and dual knockout mice revealed significantly reduced expression of Zfp277, encoding zinc finger protein 277, in tissue from M3R-deficient and dual knockout mice, and parallel changes in Zfp277 protein expression. Notably, mRNA and protein for ZNF277, the human analogue of Zfp277, were increased in human colon cancer compared to adjacent normal colon, along with parallel changes in expression of M3R.ConclusionsOur results identify a novel candidate mouse gene, Zfp277, whose expression pattern is compatible with a role in mediating divergent effects of Chrm3 and Chrm1 gene ablation on murine intestinal neoplasia. The biological importance of this observation is strengthened by finding increased expression of ZNF277 in human colon cancer with a parallel increase in M3R expression. The role of zinc finger protein 277 in colon cancer and its relationship to M3R expression and activation are worthy of further investigation.

【 授权许可】

Unknown   
© Cheng et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.